Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Odile Launay

Full professor

Université de Paris Faculté de Santé

France

Research Interests

Explore related searches

Professors in France Professors in Epidemiology Epidemiology professors in France

Articles (7)

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Shannon Bell

Professor

York University

CANADA

View details

Hermann Einsele

University Hospital Würzburg

GERMANY

View details

Itziar Casado

Instituto de Salud Pública de Navarra

SPAIN

View details

Iván Martínez-Baz

Profesor asociado

Universidad de Navarra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Odile Launay

Research Interests

Explore related searches

Articles (7)

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Vaccine certificates for international travelers in future pandemics

Collaborators (4)

Shannon Bell

Hermann Einsele

Itziar Casado

Iván Martínez-Baz

Make your next move.

Odile Launay

Research Interests

Explore related searches

Articles (7)

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Vaccine certificates for international travelers in future pandemics

Collaborators (4)

Shannon Bell

Hermann Einsele

Itziar Casado

Iván Martínez-Baz

Make your next move.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.